Year-end Sale % OFF 
Abstract
A 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET) scan of a patient with diffuse bony metastases from a poorly differentiated renal adenocarcinoma demonstrated multiple bony metastatic lesions with brisk, enhanced uptake of FDG but only faint visualizations of the brain, liver, renal cortex, and soft tissue. These FDG PET images are similar to the superscan seen on Tc-99m-methylene diphosphonate bone scintigraphy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
